Products

• Margaret Hansen Frogge, RN, MS
• Michael Thorpy, M.D.
• Bruce Cheson, M.D.
• Richard Dickens, LCSW-R
• Hagop M. Kantarjian, M.D.
• Neal Slatkin, M.D., D.A.B.P.M.

• When Good Medicines Become Bad Drugs^SM
• Cephalon to Match Employee Contributions to Aid Earthquake Relief in Haiti
• Cephalon Supports Pain Awareness Month
• The Leukemia & Lymphoma Society Partnership - Light The Night
• Oncology Nursing Society Foundation Partnership
• The Leukemia & Lymphoma Society Partnership
• National Organization for Rare Disorders Partnership
• Community Volunteers in Medicine
• The Franklin-Cephalon Partnership
• Federation of State Medical Boards
• The Partnership for a Drug-Free America
• Horst Witzel Award
• National Constitution Center Partnership

• NUVIGIL

Lesley Russell, MB.Ch.B., MRCP
Executive Vice President and Chief Medical Officer

“NUVIGIL is a prescription medicine used to improve wakefulness in adults who experience excessive sleepiness due to one of the following diagnosed sleep disorders: obstructive sleep apnea, shift work sleep disorder or narcolepsy.  In patients with obstructive sleep apnea, NUVIGIL is used along with other medical treatments for this sleep disorder.  NUVIGIL is not a replacement for your current treatment.

We're pleased that patients with treated obstructive sleep apnea, shift work disorder, and narcolepsy will now have access to NUVIGIL.

There's an extensive clinical development program in place to further study the safety and efficacy of NUVIGIL in some serious medical conditions such as bipolar depression, the negative symptoms of schizophrenia, cancer treatment related fatigue and excessive sleepiness associated with traumatic brain injury.”

Please remember individual results may vary.

NUVIGIL Prescribing Information

Full prescribing information including bolded warnings for NUVIGIL is available at www.NUVIGIL.com.